Form 4: Journey Medical Corp Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Claude Maraoui, President & CEO of Journey Medical Corp, sold 4,834 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On May 2, 2025, Claude Maraoui, President & CEO of Journey Medical Corp, sold 4,834 shares of common stock at a price of $6.84 per share.
- The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- Maraoui still owns 2,348,313 shares following the transaction, including restricted stock units that vest over various time periods.
- The sale was conducted automatically according to the Issuer's corporate policies.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and has a neutral sentiment.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation plans. The sale is unlikely to have a significant impact on the company's stock price.
Stakeholder Impact
- The sale of shares may have a minor impact on shareholders due to the small number of shares sold.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of stock sale transaction |
| 05/05/2025 | Date of Form 4 filing |
Keywords
Journey Medical Corp, Claude Maraoui, stock sale, Form 4, DERM, restricted stock units, tax withholding, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.